Lebanon National Drugs Database

This section represents the official information about the pharmaceutical products registered & marketed at the Ministry of Public Health

You can search in the form below for information related to drugs including Subsidy percentage

Drugs code ending with "/945" are subject to the Resolution 945/1 date 3/10/2022

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
D11AH05	DUPIXENT	BioTech	Dupilumab - 200mg	200mg	Injectable solution	123,001,362 L.L
L01BC08	DACOGEN	B	Decitabine - 50mg	50mg	Injectable lyophilised powder for solution	84,497,096 L.L
L01BC08	DACOGEN	B	Decitabine - 50mg	50mg	Injectable lyophilised powder for solution	84,497,096 L.L
L01EA02	DALEUBIN	G	Dasatinib - 70mg	70mg	Tablet, film coated	95,626,935 L.L
L01EA02	DASATINIB NEAPOLIS	G	Dasatinib - 70mg	70mg	Tablet, film coated	219,542,925 L.L
L01EA02	DALEUBIN	G	Dasatinib - 50mg	50mg	Tablet, film coated	94,817,102 L.L
L01EA02	DASATINIB NEAPOLIS	G	Dasatinib - 50mg	50mg	Tablet, film coated	219,541,889 L.L
L01EA02	DALEUBIN	G	Dasatinib - 20mg	20mg	Tablet, film coated	76,926,230 L.L
L01EA02	DASATINIB NEAPOLIS	G	Dasatinib - 20mg	20mg	Tablet, film coated	105,380,480 L.L
L01EA02	DASATINIB NEAPOLIS	G	Dasatinib - 140mg	140mg	Tablet, film coated	486,544,291 L.L
L01EA02	DASATINIB NEAPOLIS	G	Dasatinib - 140mg	140mg	Tablet, film coated	256,075,943 L.L
L01FC01	DARZALEX	BioTech	Daratumumab - 400mg/20ml	400mg/20ml	Injectable concentrate for solution	160,134,596 L.L
L01FC01	DARZALEX	BioTech	Daratumumab - 100mg/5ml	100mg/5ml	Injectable concentrate for solution	45,091,167 L.L
L01FC01	DARZALEX	BioTech	Daratumumab - 1800mg	1800mg	Injectable solution	480,402,659 L.L
L02AE04	DECAPEPTYL LP	B	Triptorelin (pamoate) - 11.25mg	11.25mg	Injectable powder for suspension+diluent	31,761,098 L.L
V03AC03	DIFIRAX	G	Deferasirox - 250mg	250mg	Tablet, dispersible	21,667,822 L.L
V03AC03	DIFIRAX	G	Deferasirox - 250mg	250mg	Tablet, dispersible	23,213,276 L.L

...